Best TWAS P=1.41e-12 · Best GWAS P=1.59e-09 conditioned to 6.96e-07
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | CAMLG | 0.39 | 0.35 | lasso | 6 | 0.34 | 1.8e-42 | -5.90 | -5.9 | 4.4e-09 | 0.93 | 0.01 | 0.99 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | SAR1B | 0.12 | 0.06 | lasso | 6 | 0.09 | 8.1e-11 | -6.04 | -5.3 | 1.2e-07 | 0.85 | 0.00 | 1.00 | FALSE |
3 | GTEx | Adipose Visceral Omentum | CAMLG | 0.15 | 0.11 | lasso | 1 | 0.10 | 1.0e-05 | -5.78 | -5.8 | 7.5e-09 | 0.95 | 0.01 | 0.98 | FALSE |
4 | GTEx | Artery Aorta | CAMLG | 0.22 | 0.17 | lasso | 3 | 0.12 | 2.2e-07 | -5.87 | -5.9 | 4.4e-09 | 0.93 | 0.01 | 0.99 | FALSE |
5 | GTEx | Artery Coronary | CAMLG | 0.27 | 0.20 | lasso | 8 | 0.12 | 5.3e-05 | -5.91 | -5.9 | 3.4e-09 | 0.94 | 0.01 | 0.99 | FALSE |
6 | GTEx | Artery Tibial | CAMLG | 0.11 | 0.11 | lasso | 1 | 0.09 | 9.1e-08 | -5.87 | -5.9 | 4.4e-09 | 0.93 | 0.01 | 0.99 | FALSE |
7 | GTEx | Brain Cerebellar Hemisphere | TXNDC15 | 0.51 | 0.48 | lasso | 5 | 0.47 | 1.2e-13 | -5.06 | -5.2 | 1.6e-07 | 0.72 | 0.24 | 0.76 | FALSE |
8 | GTEx | Brain Cerebellar Hemisphere | CAMLG | 0.42 | 0.24 | lasso | 8 | 0.20 | 8.8e-06 | -5.91 | -5.5 | 5.0e-08 | 0.93 | 0.01 | 0.99 | FALSE |
9 | GTEx | Brain Cerebellum | CAMLG | 0.31 | 0.27 | lasso | 13 | 0.24 | 7.5e-08 | -5.78 | -5.9 | 4.2e-09 | 0.95 | 0.01 | 0.98 | FALSE |
10 | GTEx | Brain Cortex | CAMLG | 0.23 | 0.28 | lasso | 10 | 0.26 | 1.1e-07 | -5.78 | -5.8 | 7.5e-09 | 0.95 | 0.01 | 0.98 | FALSE |
11 | GTEx | Brain Frontal Cortex BA9 | CAMLG | 0.36 | 0.30 | lasso | 5 | 0.26 | 1.2e-07 | -5.87 | -6.0 | 2.2e-09 | 0.93 | 0.01 | 0.99 | FALSE |
12 | GTEx | Brain Hypothalamus | CAMLG | 0.28 | 0.28 | lasso | 4 | 0.25 | 1.3e-06 | -5.78 | -5.8 | 7.0e-09 | 0.95 | 0.01 | 0.98 | FALSE |
13 | GTEx | Brain Nucleus accumbens basal ganglia | CAMLG | 0.29 | 0.25 | enet | 8 | 0.32 | 2.3e-09 | -5.90 | -6.0 | 2.7e-09 | 0.92 | 0.01 | 0.99 | FALSE |
14 | GTEx | Brain Putamen basal ganglia | TXNDC15 | 0.39 | -0.01 | enet | 22 | 0.06 | 1.6e-02 | 2.53 | -5.3 | 1.5e-07 | 0.37 | 0.04 | 0.08 | FALSE |
15 | GTEx | Cells EBV-transformed lymphocytes | PHF15 | 0.26 | 0.18 | lasso | 6 | 0.22 | 7.1e-08 | 4.29 | 5.4 | 6.9e-08 | -0.30 | 0.49 | 0.33 | FALSE |
16 | GTEx | Cells Transformed fibroblasts | TXNDC15 | 0.38 | 0.31 | lasso | 11 | 0.33 | 4.8e-25 | -5.16 | 5.2 | 2.4e-07 | -0.74 | 0.43 | 0.57 | FALSE |
17 | GTEx | Colon Sigmoid | TXNDC15 | 0.19 | 0.12 | lasso | 6 | 0.10 | 1.6e-04 | -5.84 | -5.9 | 3.1e-09 | 0.94 | 0.01 | 0.98 | FALSE |
18 | GTEx | Colon Sigmoid | CAMLG | 0.16 | 0.01 | lasso | 3 | 0.00 | 2.9e-01 | -5.91 | -5.4 | 8.5e-08 | 0.88 | 0.02 | 0.85 | FALSE |
19 | GTEx | Colon Transverse | TXNDC15 | 0.22 | -0.01 | lasso | 7 | -0.01 | 6.8e-01 | -5.06 | -5.5 | 4.8e-08 | 0.74 | 0.02 | 0.78 | FALSE |
20 | GTEx | Colon Transverse | SAR1B | 0.11 | 0.00 | enet | 17 | 0.03 | 1.2e-02 | -5.84 | -6.7 | 1.7e-11 | 0.58 | 0.02 | 0.74 | TRUE |
21 | GTEx | Esophagus Muscularis | CAMLG | 0.23 | 0.17 | lasso | 5 | 0.15 | 1.3e-09 | -5.91 | -5.9 | 4.0e-09 | 0.95 | 0.01 | 0.99 | FALSE |
22 | GTEx | Heart Atrial Appendage | CAMLG | 0.14 | 0.03 | lasso | 4 | 0.03 | 2.0e-02 | -5.90 | -5.6 | 2.3e-08 | 0.90 | 0.01 | 0.95 | FALSE |
23 | GTEx | Lung | CAMLG | 0.11 | 0.11 | enet | 7 | 0.11 | 9.1e-09 | -5.87 | -6.1 | 1.3e-09 | 0.93 | 0.01 | 0.99 | FALSE |
24 | GTEx | Muscle Skeletal | SAR1B | 0.10 | 0.04 | lasso | 7 | 0.04 | 6.1e-05 | 2.80 | -5.5 | 3.5e-08 | 0.62 | 0.02 | 0.92 | FALSE |
25 | GTEx | Muscle Skeletal | CAMLG | 0.08 | 0.01 | enet | 28 | 0.05 | 2.0e-05 | -0.17 | -6.3 | 2.4e-10 | 0.43 | 0.02 | 0.61 | TRUE |
26 | GTEx | Nerve Tibial | CAMLG | 0.25 | 0.19 | lasso | 5 | 0.19 | 1.5e-13 | -5.84 | -5.9 | 3.7e-09 | 0.95 | 0.01 | 0.99 | FALSE |
27 | GTEx | Pituitary | CAMLG | 0.20 | 0.07 | enet | 10 | 0.09 | 3.3e-03 | -5.78 | -5.8 | 7.2e-09 | 0.92 | 0.01 | 0.98 | FALSE |
28 | GTEx | Skin Sun Exposed Lower leg | CAMLG | 0.11 | 0.05 | lasso | 2 | 0.03 | 2.9e-03 | -5.78 | -5.9 | 4.5e-09 | 0.92 | 0.01 | 0.98 | TRUE |
29 | GTEx | Thyroid | TXNDC15 | 0.24 | 0.22 | enet | 8 | 0.24 | 3.0e-18 | -5.16 | -5.2 | 2.2e-07 | 0.70 | 0.43 | 0.57 | FALSE |
30 | GTEx | Thyroid | CAMLG | 0.21 | 0.21 | lasso | 5 | 0.21 | 3.3e-16 | -5.78 | -5.9 | 3.9e-09 | 0.95 | 0.01 | 0.99 | FALSE |
31 | METSIM | Adipose | CAMLG | 0.14 | 0.18 | enet | 8 | 0.21 | 4.0e-30 | -5.87 | -5.8 | 5.6e-09 | 0.94 | 0.01 | 0.99 | FALSE |
32 | METSIM | Adipose | SAR1B | 0.06 | 0.02 | bslmm | 288 | 0.03 | 3.1e-05 | -5.90 | -7.1 | 1.4e-12 | 0.66 | 0.01 | 0.97 | TRUE |
33 | ROSMAP | Brain Pre-frontal Cortex | TXNDC15 | 0.19 | 0.10 | bslmm | 324 | 0.14 | 1.2e-17 | -5.06 | -5.1 | 2.6e-07 | 0.62 | 0.33 | 0.67 | FALSE |
34 | ROSMAP | Brain Pre-frontal Cortex | CAMLG | 0.47 | 0.52 | lasso | 8 | 0.52 | 2.2e-79 | -5.90 | -5.9 | 3.2e-09 | 0.94 | 0.01 | 0.99 | FALSE |
35 | YFS | Blood | CAMLG | 0.12 | 0.19 | bslmm | 295 | 0.20 | 1.2e-61 | -5.87 | -6.0 | 2.2e-09 | 0.92 | 0.01 | 0.99 | FALSE |
36 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | CAMLG | 0.10 | 0.04 | blup | 17 | 0.04 | 2.2e-04 | -5.90 | -5.3 | 1.3e-07 | 0.28 | 0.00 | 0.96 | TRUE |
37 | The Cancer Genome Atlas | Breast Invasive Carcinoma | TXNDC15 | 0.05 | 0.06 | lasso | 3 | 0.06 | 1.9e-11 | -5.14 | 5.3 | 9.4e-08 | -0.77 | 0.15 | 0.85 | FALSE |
38 | The Cancer Genome Atlas | Colon Adenocarcinoma | TXNDC15 | 0.13 | 0.08 | blup | 43 | 0.09 | 9.7e-06 | -5.14 | 5.9 | 4.2e-09 | -0.75 | 0.09 | 0.87 | FALSE |
39 | The Cancer Genome Atlas | Glioblastoma Multiforme | CAMLG | 0.29 | 0.18 | lasso | 3 | 0.13 | 9.6e-05 | -5.90 | -6.1 | 8.6e-10 | 0.92 | 0.00 | 0.99 | FALSE |
40 | The Cancer Genome Atlas | Glioblastoma Multiforme | TXNDC15 | 0.27 | 0.07 | lasso | 2 | 0.11 | 3.2e-04 | -5.06 | 5.2 | 2.4e-07 | -0.74 | 0.03 | 0.46 | FALSE |
41 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | CAMLG | 0.05 | 0.01 | blup | 18 | 0.02 | 1.4e-03 | -5.90 | -5.1 | 2.9e-07 | 0.35 | 0.00 | 0.69 | FALSE |
42 | The Cancer Genome Atlas | Brain Lower Grade Glioma | CAMLG | 0.08 | 0.05 | lasso | 1 | 0.04 | 1.8e-05 | -5.90 | -5.9 | 3.6e-09 | 0.93 | 0.00 | 1.00 | FALSE |
43 | The Cancer Genome Atlas | Lung Adenocarcinoma | TXNDC15 | 0.05 | 0.05 | lasso | 1 | 0.04 | 1.0e-05 | -5.16 | 5.2 | 2.5e-07 | -0.73 | 0.14 | 0.84 | FALSE |
44 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | TXNDC15 | 0.03 | 0.03 | blup | 35 | 0.03 | 5.6e-04 | -5.06 | 5.2 | 1.7e-07 | -0.78 | 0.02 | 0.85 | FALSE |
45 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | TXNDC15 | 0.23 | 0.21 | enet | 10 | 0.20 | 1.1e-08 | -5.16 | 5.4 | 6.9e-08 | -0.81 | 0.03 | 0.97 | FALSE |
46 | The Cancer Genome Atlas | Prostate Adenocarcinoma | CAMLG | 0.13 | 0.07 | lasso | 3 | 0.05 | 2.0e-06 | -5.90 | -5.9 | 4.3e-09 | 0.92 | 0.00 | 1.00 | FALSE |
47 | The Cancer Genome Atlas | Prostate Adenocarcinoma | TXNDC15 | 0.07 | 0.04 | lasso | 4 | 0.04 | 6.2e-05 | -5.06 | 5.3 | 1.1e-07 | -0.76 | 0.07 | 0.74 | FALSE |
48 | The Cancer Genome Atlas | Thyroid Carcinoma | CAMLG | 0.26 | 0.21 | lasso | 2 | 0.21 | 5.2e-20 | -5.90 | -5.9 | 4.9e-09 | 0.93 | 0.00 | 1.00 | FALSE |